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Abstract
Transforming growth factor beta (TGF-b) has been implicated in the pathogenesis of several diseases including infection
with intracellular pathogens such as the Mycobacterium avium complex. Infection of macrophages with M. avium induces
TGF-b production and neutralization of this cytokine has been associated with decreased intracellular bacterial growth. We
have previously demonstrated that epithelioid cell surrogates (ECs) derived from primary murine peritoneal macrophages
through a process of differentiation induced by IL-4 overlap several features of epithelioid cells found in granulomas. In
contrast to undifferentiated macrophages, ECs produce larger amounts of TGF-b and inhibit the intracellular growth of M.
avium. Here we asked whether the levels of TGF-b produced by ECs are sufficient to induce a self-sustaining autocrine TGF-b
signaling controlling mycobacterial replication in infected-cells. We showed that while exogenous addition of increased
concentration of TGF-b to infected-macrophages counteracted M. avium replication, pharmacological blockage of TGF-b
receptor kinase activity with SB-431542 augmented bacterial load in infected-ECs. Moreover, the levels of TGF-b produced
by ECs correlated with high and sustained levels of ERK1/2 activity. Inhibition of ERK1/2 activity with U0126 increased M.
avium replication in infected-cells, suggesting that modulation of intracellular bacterial growth is dependent on the
activation of ERK1/2. Interestingly, blockage of TGF-b receptor kinase activity with SB-431542 in infected-ECs inhibited ERK1/
2 activity, enhanced intracellular M. avium burden and these effects were followed by a severe decrease in TGF-b
production. In summary, our findings indicate that the amplitude of TGF-b signaling coordinates the strength and duration
of ERK1/2 activity that is determinant for the control of intracellular mycobacterial growth.
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Introduction
Bacteria of the Mycobacterium avium complex are facultative
intracellular microorganisms that mainly infect mononuclear
phagocytes and cause disseminated infection in immunocompro-
mised patients [1,2]. The mycobacteria gain access to host tissues
by a variety of portals [3,4], and invade the mucosa via epithelial
cells [5,6]. Once the bacteria are transported into the deeper
tissues by macrophages and perhaps other phagocytic cells,
additional macrophages gather at individual infected foci to form
granulomas. Granulomas likely begin as aggregates of mononu-
clear phagocytes that surround individual infected macrophages
[7,8]. These macrophages become activated, a transformation
reflected by an increase in their size and subcellular organelles,
ruffled cell membranes, and enhanced phagocytic and microbici-
dal capabilities [9,10]. A common feature of all Mycobacterium
granulomas is the differentiation of macrophages into epithelioid
cells that have tightly interdigitated cell membranes in zipper-like
arrays linking adjacent cells [7,10]. It is speculated that
mycobacteria enter into a latent phase within mature granulomas
and remain contained within these structures for prolonged
periods of time [11].
Several studies have shown that the transforming growth factor
b (TGF-b) is produced by macrophages upon infection with
Mycobacterium and also with other pathogens and that the presence
of TGF-b favors virulence, probably through its immunosuppres-
sive action by impairing the response of macrophages to cytokines
such as TNF-a or by suppression of nitric oxide (NO), and reactive
oxygen intermediates [12,13,14]. TGF-b is a pleiotropic cytokine
produced by every leukocyte lineage, including lymphocytes,
macrophages, and dendritic cells, and its expression serves in both
autocrine and paracrine modes to control the differentiation,
proliferation, and state of activation of these immune cells [15,16].
The action of TGF-b on these cells is dependent not only on the
cell type and its state of differentiation, but also on the milieu of
cytokines present [17], suggesting that perturbations of the balance
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21465of this cytokine array may also alter effects of TGF-b and
contribute to immunopathology. TGF-b exerts its effect through
heteromeric receptor complex consisting of type I and type II
transmembrane serine/threonine kinase receptors. Upon ligand
binding TGF-b receptor recruits and activates Smad family
members or activates Smad-independent signaling pathways such
as the mitogen-activated protein kinase (MAPK) pathway [18].
Although TGF-b regulates several MAPK pathways, the mode of
activation appears to be highly variable and cell type-dependent
[18,19,20].
Besides the role of TGF-b favoring mycobacterium replication,
it has been shown that mycobacterium can directly interfere with
host-cell signaling pathways. Examples are the studies showing
that entry of a virulent M. avium strain causes little activation of the
p38 and ERK1/2 MAPKs in macrophages, whereas low or
intermediated strain are potent inducers [21,22,23]. Moreover,
inhibition of the ERK1/2 but not of the p38 pathway further
enhanced intracellular growth of highly replicative M. avium
strains, showing that pathogenic mycobacteria have evolved
mechanisms to prevent a sustained activation of ERK1/2, and
this may account for their intracellular growth [21]. Despite
significant advances concerning the mechanisms of interaction and
the consequent changes that are induced by mycobacterium in the
macrophage signaling machinery, critical gaps remain in our
understanding about a possible relationship between TGF-b
signaling and ERK1/2 controlling mycobacterium replication in
infected cells.
We have previously shown that epithelioid cell surrogates (ECs)
derived from primary murine peritoneal macrophages through a
process of differentiation induced by recombinant IL-4 (rIL-4),
overlap several morphological and functional features of epithe-
lioid cells found in granulomas [24]. In contrast to undifferentiated
macrophages, ECs secrete high amounts of TGF-b and are
efficient in inhibiting the intracellular growth of M. avium [25]. In
the present study, we employed this cell system to investigate
whether there is a relationship between the magnitude of TGF-b
signaling and activation of ERK1/2 in the regulation of
intracellular growth kinetics of M. avium.
Results
The type II IL-4R is the functional receptor involved in the
signaling pathway leading to macrophage differentiation
into ECs
We have previously described that primary murine peritoneal
macrophages pulsed with recombinant IL-4 (rIL-4) acquire
morphological and functional characteristics of epithelioid cells
after 7 days in culture [24], suggesting that signaling through IL-4
receptor is involved in the differentiation of macrophages into
epithelioid cells surrogates (ECs). IL-4 is structurally similar and
shares a functional signaling receptor chain with IL-13 [26,27] and
therefore, both cytokines can hold similar biological and
immunoregulatory functions. Based on this premise we asked
whether IL-13 could also promote differentiation of macrophages
into ECs. To test this, peritoneal macrophages were pulsed with
recombinant IL-13 (rIL-13) and after 7 days morphological and
functional analysis were performed. As shown in Fig. 1, in contrast
to untreated macrophages which showed morphology elongated,
rIL-13-treated cells became grouped together and assumed a
‘‘fried-egg’’ shape, similar to ECs as previously described by
Cipriano et al [24]. Among the functional features of ECs those
include the ability to overcome intracellular M. avium replication as
well as overproduction of TGF-b [25]. As shown in Fig. 2A, the
behavior of rIL-13-treated macrophages upon infection with M.
avium revealed that the number of bacilli/cell was lower
throughout the course of infection, compared to the increased
growth seen in untreated cells. Also the kinetics of TGF-b
production during the 7 days culture of macrophages pulsed on
day one with rIL-13 or rIL-4 were similarly increased in a time
dependent manner (Fig. 2B). Moreover, TGF-b production was
also as much higher in rIL-13-treated macrophages as in ECs
during the course of M. avium infection (Fig. 2C). Taking together
these results show that like rIL-4, rIL-13 was capable to induce
morphological and functional changes that are representative of
ECs, suggesting that both cytokines induce the same functional
receptor involved in the differentiation process.
High TGF-b levels produced by ECs mediate the
inhibition of M. avium replication in infected-cells
The ability of ECs to overproduce TGF-b even during the
course of M. avium infection suggests that high levels of this
cytokine play a role inhibiting bacilli replication in infected-cells in
an autocrine fashion. To test this hypothesis, we first checked
Figure 1. Primary peritoneal macrophages treated with rIL-13
display morphological features of ECs. (A) Untreated primary
peritoneal macrophages and (B) primary peritoneal macrophages
pulsed with rIL-13 (10 ng ml
21) on day one. After 7 days, cell
monolayers were examined for morphological changes by phase
contrast inverted light microscopy. Scale bar=50 mm.
doi:10.1371/journal.pone.0021465.g001
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higher concentration of TGF-b could overcome M. avium growth
like we observe in cultures of infected-ECs. Therefore, macro-
phages were treated with 100 pg/ml of recombinant TGF-b
(rTGF-b) 4 h post-infection and then the same concentration of
rTGF-b was added each 24 h during the course of infection. The
concentration of rTGF-b used in this experiment was based on the
concentration of TGF-b secreted in the conditioned medium
(,150 pg/ml) from ECs cultures, which is higher than the TGF-b
concentration found in the conditioned medium from undifferen-
tiated macrophages cultures (,50 pg/ml) [25]. As shown in
Fig. 3A, treatment of macrophages with 100 pg/ml of rTGF-b
overrode macrophages capability to increase M. avium replication
when compared to untreated cells. In addition, to rule out that
rTGF-b itself affects bacilli replication, we performed a growth
curve of M. avium in the presence or absence of different
concentrations of rTGF-b. Our result showed that even in the
presence of high concentrations of rTGF-b, M. avium growth was
not modulated by the presence of the cytokine (Fig. S1).
To verify the functional role of TGF-b signaling itself,
macrophages and ECs were treated with a potent and selective
inhibitor of TGF-b type I receptor kinase activity [28]. SB-431542
is a very stable inhibitor being effective for up to 60 h in inhibition
assays [28]. Therefore, macrophages and ECs were pre-treated
with SB-431542 for 1 h and then infected with M. avium. As shown
in Fig. 3B, treatment with SB-431542 significantly increased the
intracellular growth of M. avium in infected-ECs, suggesting
involvement of TGF-b signaling in the regulation of intracellular
M. avium replication. Although in this experiment infected
macrophages treated with SB-431542 showed a slight decrease
in bacilli growth (Fig. 3B), this effect was not statistically significant
when compared to untreated macrophages. Considering that
infected-macrophages produce much less TGF-b than infected-
ECs, it is possible that the amounts of TGF-b secreted by these
cells may not be sufficient to stimulate TGF-b signaling to an
extent that is necessary for the inhibition of M. avium replication.
Therefore, even after inhibition of receptor activity with SB-
431542, it was expected that the rates of M. avium growth would
remain somewhat unchanged in infected-macrophages. Addition-
ally, we also quantified TGF-b secretion in the culture medium
from cells submitted to the experiment described above. As
expected, TGF-b levels increased during the kinetics of infection in
untreated-ECs cultures, whereas in untreated-macrophages the
levels were much lower (Fig. 3C). In cultures of infected-ECs
treated with SB-431542, TGF-b levels were drastically diminished
compared to untreated infected-ECs. In SB-431542-treated
infected macrophages TGF-b levels were not altered compared
with their untreated counterparts, except at 4 h post-infection
were TGF-b levels significantly dropped (Fig. 3C). Together, these
results suggest that signaling through TGF-b receptor is not only
involved in the regulation of intracellular M. avium growth, but also
points to the presence of an autoregulatory feedback loop of TGF-
b production, since inhibition of TGF-b receptor activity
correlated with diminished TGF-b production in ECs.
TGF-b-mediated inhibition of M. avium growth involves
activation of ERK1/2
To check whether TGF-b-mediated inhibition of M. avium
growth in infected- ECs involves the activation of ERK1/2
MAPK, we first analyzed the status of ERK1/2 phosphorylation
during the course of differentiation of macrophages into ECs.
Therefore, macrophages were pulsed with rIL-4 on day 1 and after
5, 6 and 10 days cells were harvested for Western blot analysis of
ERK1/2 phosphorylation. As shown in Fig. 4A, a strong
Figure 2. rIL-13-treated macrophages inhibit M. avium replica-
tion and secrete high amounts of TGF-b. (A) Kinetics of M. avium
infectionexpressedasbacilli/cellincontrolmacrophages(squares)andinrIL-
13-treatedmacrophages(triangles)cultures.Resultsaremeans6S.E.M.from
a representative experiment among two carried out in duplicates. *P,0.05
and **P,0.01 when untreated macrophages are compared to rIL-13 treated
macrophages at the same time point. (B) TGF-b measurement expressed as
meanconcentration6S.E.M.obtaineddaybydayfromculturesupernatants
of macrophages pulsed either with rIL-4 (open bars) or rIL-13 (hatched bars),
by sandwich ELISA. Black bars represent the mean concentration of TGF-b in
untreated macrophages cultures. (C) TGF-b measurement in the cell culture
supernatant of M. avium-infected cells. Infected-macrophages (black bars),
infected-ECs (open bars) and infected rIL-13-treated macrophages (hatched
bars). *P,0.05 when ECs and rIL-13-treated cells were compared to control
macrophages at the same time point.
doi:10.1371/journal.pone.0021465.g002
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remained highly phosphorylated on day 10, indicating that
ERK1/2 phosphorylation is induced at the final steps of the
differentiation process, remaining highly phosphorylated after
differentiation.
We also investigated the status of ERK1/2 phosphorylation in
infected-cells. Macrophages and ECs were either infected or not
with M. avium and 4 h and 96 h post-infection cells were harvested
for analysis of ERK1/2 phosphorylation. Figure 4B shows that in
contrast to uninfected-macrophages, ERK1/2 was highly phos-
phorylated in uninfected-ECs. Phosphorylation of ERK1/2 was
induced in macrophages 4 h post-infection, which slightly
increased 96 h post-infection. On the other hand, infected-ECs
showed similar band intensities of ERK1/2 phosphorylation in
both times post-infection, which were as intense as in uninfected-
ECs, however stronger than in infected-macrophages. This result
suggests that ECs achieved a saturation of ERK1/2 activation that
was no longer increased upon infection with M. avium, a condition
that was opposed in macrophages where ERK1/2 activation was
induced only after infection. These different modulations of
ERK1/2 activity between ECs and macrophages imply that a
proper balance in the magnitude and duration of ERK1/2 activity
might be determinant in providing a specific intracellular milieu for
the control of M. avium replication.
To check whether ERK1/2 activity in ECs was dependent on
the activation of the TGF-b receptor signaling, ECs were pre-
treated with the TGF-b receptor inhibitor SB-431542 and
submitted to infection with M. avium for evaluation of ERK1/2
phosphorylation. As shown in Fig. 4C, ERK1/2 phosphorylation
was greatly inhibited by SB-431542, irrespective if ECs were
infected or not. Moreover, to test if ERK1/2 activation was
playing a role in the inhibition of M. avium growth, ECs were pre-
treated with U0126, a well-established inhibitor of the ERK1/2
pathway, and then infected or not with M. avium. Figure 4D shows
that replication of M. avium was significantly increased in U0126-
treated ECs, an effect that was similar to the replication rates seen
in untreated infected-macrophages, suggesting that enhanced
ERK1/2 activity indeed favors the inhibition of M. avium growth
in ECs.
Inhibition of intracellular pathogens growth in ECs is
pathogen-dependent
To gain further insight into the mechanism involved in the
control of M. avium replication in ECs, we questioned whether this
effect was pathogen-dependent. To answer this question we choose
two taxonomically unrelated intracellular pathogens, including the
dimorphic fungus Paracoccidioides brasiliensis (P. brasiliensis) and the
protozoan parasite Leishmania amazonensis (L. amazonensis). Both
pathogens are known to infect mononuclear phagocytes and also
to induce granuloma formation in infected mice [29,30,31].
Therefore, macrophages and ECs were submitted to infection
either with P. brasiliensis, L. amazonensis amastigotes or M. avium to
assess the intracellular growth behavior of these pathogens in
infected cells. As shown in Fig. 5, four hours post-infection, the
uptake of each pathogen into macrophages and ECs was similar.
The kinetics of infection revealed that like M. avium, replication of
Figure 3. TGF-b signaling is involved in the regulation of
intracellular M. avium growth. (A) Addition of rTGF-b into M. avium-
infected macrophages. Results show the number of bacilli/cell in
macrophages treated with rTGF-b (100 pg ml
21) 4 h post-infection,
followed by rTGF-b addition each 24 h during the course of infection.
*P,0.05 when treated macrophages (open squares) where compared
to untreated macrophages (full squares) at each time point. Results are
representative of two independent experiments done in duplicates. (B)
Number of bacilli/cell in M. avium-infected cells. (Open triangles)
SB431542-treated ECs, (open squares) SB-431542-treated macrophages,
(full triangles) untreated ECs and (full squares) untreated macrophages.
SB431542 (100 mM) was added 1 h before cell/bacilli co-incubation.
*P,0.05 when untreated and treated ECs are compared. There is not
statistical difference when treated and untreated macrophages are
compared. (C) TGF-b measurement in the culture supernatants of M.
avium-infected cells. (Hatched bars) SB431542-treated macrophages,
(grey bars) SB431542-treated ECs, untreated macrophages (black bars),
untreated ECs (open bars). SB431542 (100 mM) was added 1 h before
cell/bacilli co-incubation. *P,0.05 when treated macrophages were
compared to untreated ones and
#P,0.05 when treated ECs were
compared to untreated ones at each time point. Results from one
experiment among two carried out in duplicates.
doi:10.1371/journal.pone.0021465.g003
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the number of L. amazonensis parasites in ECs underwent
replication above the rates seen in infected-macrophages (Fig. 5
C). Additionally, we quantified TGF-b secretion in the culture
medium from cells submitted to infection with the pathogens
described above. As shown in Fig. 6, like M. avium, both P.
brasiliensis and L. amazonensis induced increased TGF-b secretion in
infected-ECs cultures, showing similar levels of the cytokine 96 h
post-infection. Although TGF-b levels from cultures of L.
amazonensis-infected macrophages were significantly higher com-
pared to macrophages infected either with M. avium or P. brasiliensis,
the overall production of TGF-b in infected-macrophages were still
Figure 5. M. avium and P. brasiliensis but not L. amazonensis
replication is inhibited in infected-ECs. Kinetics of infection in
macrophages (squares) and in ECs (triangles) expressed as pathogen/
cell. (A) M. avium (rate of infection 50:1). (B) P. brasiliensis (rate of
infection 5:1). (C) L. amazonensis (rate of infection 2:1). Results are
representative of 3 experiments done in duplicates. *P,0.05 when
macrophages and ECs are compared at each time point.
doi:10.1371/journal.pone.0021465.g005
Figure 4. ERK1/2 is involved in TGF-b-mediated inhibition of M.
avium replication. (A) Macrophages were pulsed with rIL-4 on day
one and after 5, 6 and 10 days, cells were collected and submitted to
immunoblotting for detection of ERK1/2 phosphorylation. Total ERK1/2
was detected as control for protein loading. (B) Macrophages and ECs
were infected or not with M. avium at the indicated times post-infection
and phosphorylation of ERK1/2 was detected by immunoblotting. Total
ERK1/2 was detected as control for protein loading. (C) ECs were either
infected or not with M. avium and pre-treated or not with SB431542
one hour before infection. Four hours post-infection cells were
collected and submitted to immunoblotting for detection of ERK1/2
phosphorylation. Total ERK1/2 was detected as control for protein
loading. (D) Kinetics of M. avium-infection on ECs (full triangles),
macrophages (full squares) and ECs treated with U0126 (10 mM) 24 h
before infection (open triangles). *P#0.05 when macrophages and
U0126-treated ECs are compared with untreated ECs.
doi:10.1371/journal.pone.0021465.g004
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show that in ECs TGF-b-mediated inhibition of intracellular
parasites growth is pathogen-dependent.
Discussion
The persistence of M. avium at sites of infection is due in part to
high resistance of these microorganisms to microbicidal devices of
host macrophages. Once within the macrophage, this facultative
intracellular pathogen must commandeer the host cell machinery
to enable its own multiplication and survival. However, the
mechanisms by which this is accomplished are largely unknown.
One possible device implicated in this effect might involve
immunoregulatory mediators such as TGF-b, since it has been
shown that this cytokine is endogenously produced by macro-
phages infected with M. avium [32,33,34,35]. It is believed that
TGF-b favors intracellular M. avium growth by impairing the
response of macrophages to cytokines such as TNF-a or by
suppression of nitric oxide (NO), and reactive oxygen intermedi-
ates [12,13,14]. The data presented in this report have shown that
the role of TGF-b favoring intracellular microbial growth is not
that straightforward, but greatly depends on the amplitude of
TGF-b signaling coordinating the strength and duration of
ERK1/2 activity.
We used epithelioid cell surrogates (ECs) to investigate the
biological role of TGF-b interfering with the intracellular growth
of M. avium, since these cells produce high levels of TGF-b and are
efficient in inhibiting the intracellular growth of M. avium [25]. ECs
were established from primary murine peritoneal macrophages
through a process of differentiation induced by recombinant IL-4
(rIL-4) and are distinct from dendritic cells differentiated from
human peripheral blood monocytes using rIL-4/rGM-CSF
[24,25]. In this report, we add new insight about the functional
receptor involved in the signaling pathway leading to macrophage
differentiation into ECs. We have demonstrated that like rIL-4,
treatment with rIL-13 also induced morphological and functional
differentiation of macrophages into ECs. In fact, both IL-4 and IL-
13 receptors are multimeric and share at least one common chain
called IL-4Ra. The IL-4Ra chain binds IL-4 leading to
dimerization with proteins to form either a type I or type II
receptor. The type I receptor arises by recruitment of a common
gamma chain (cC) while the type II is formed by interaction of IL-
4Ra with IL-13Ra1 instead of cC [26,27]. IL-13 binds to IL-
13Ra1 inducing heterodimerization with IL-4Ra to form a
complex identical to the type II IL-4R, which is able to transduce
both IL-4 and IL-13 signals [36]. Therefore, our results suggest
that the type II IL-4R is the functional receptor involved in the
signaling pathway leading to macrophage differentiation into ECs,
thus explaining the striking overlapping actions of IL-4 and IL-13
in our model.
To demonstrate that high TGF-b levels produced by ECs play a
role in the inhibition of intracellular M. avium growth, we used two
strategies. First, we treated infected-macrophages with a concen-
tration of rTGF-b that is related to the concentration of TGF-b
secreted in the culture medium of ECs culture. Our results showed
that increased TGF-b levels overrode macrophages capability to
enhance intracellular M. avium growth, similarly to that observed
in infected-ECs. Second, we blocked TGF-b receptor kinase
activity in infected-ECs with SB-431542, which significantly
increased bacterial replication rates. Interestingly, in contrast to
SB-431542-treated infected macrophages, TGF-b levels were
drastically diminished in the culture medium of infected-ECs
treated with SB-431542, suggesting that signaling through TGF-b
receptor is not only involved in the inhibition of M. avium growth,
but also that high TGF-b levels act autocrinally to regulate its own
expression in ECs. This positive autocrine loop of TGF-b may be
Figure 6. Infected-ECs secrete high levels of TGF-b irrespective of the nature of the infecting pathogen. TGF-b measurement in the
culture supernatants of macrophages and ECs infected with different pathogens, as indicated, at 3 time points after infection: open bars, 4 h; grey
bars, 48 h and black bars, 96 h. Insert: basal levels of TGF-b in macrophages (black bar) and ECs (open bar) in the absence of infection. Results are
representative of two experiments done in duplicates. *P,0.05 when compared to uninfected macrophages and
#P,0.05 when compared to
uninfected ECs.
doi:10.1371/journal.pone.0021465.g006
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inhibition of M. avium replication, suggesting that the amplitude of
TGF-b signaling is an important determinant of infection
outcome.
TGF-b exerts its effects through heteromeric receptor complex
consisting of type I and type II transmembrane serine/threonine
kinase receptors. Smad family members and MAPKs such as
ERK1/2 have been implicated in the signaling by TGF-b
[37,38,39]. Moreover, there is an emerging consensus that
replication of M. avium in murine macrophages is inhibited by
activated ERK1/2 [21,40]. Our data demonstrated that during
the course of differentiation of macrophages into ECs ERK1/2
phosphorylation was induced on day 6, remaining phosphorylated
after completion of differentiation, showing that unlike macro-
phages ERK1/2 activity is sustained in ECs. We do not know yet
the mechanism responsible for this effect. However, based on our
data showing a time-dependent increase of TGF-b production
during the course of macrophages differentiation (Fig. 2B), we
argue that the amounts of TGF-b produced from day 6 on could
be the critical threshold concentration of TGF-b necessary to
stimulate TGF-b signaling to an extent that is capable to induce
and maintain long-term ERK1/2 activity in ECs. This magnitude
of ERK1/2 activation could in turn modulate ECs function
towards the inhibition of M. avium growth. Indeed, when we
checked ERK1/2 phosphorylation in M. avium infected-cells, we
showed that in ECs high levels of phosphorylated ERK1/2
remained almost unchanged even upon infection, a condition that
was opposed in macrophages in which ERK1/2 phosphorylation
was induced only after infection. Interestingly, blocking TGF-b
receptor activity with SB-431542 greatly inhibited ERK1/2
phosphorylation in infected as well as in uninfected-ECs, showing
that ERK1/2 activity is dependent on TGF-b signaling.
Moreover, inhibition of ERK1/2 activity with U0126 significantly
increased M. avium replication rates in infected-ECs. Together,
these results suggest that a proper balance in the magnitude and
duration of ERK1/2 activity may be determinant for infected-cells
to control mycobacterial growth.
In effect, there is an emerging concept from the recent literature
placing ERK1/2 as an important regulator of M. avium replication
in macrophages. It has been shown that inhibition of the ERK1/2
but not of the p38 pathway further enhanced intracellular growth
of highly replicative M. avium strain, showing that pathogenic
mycobacteria have evolved mechanisms to prevent a sustained
activation of ERK1/2, and this may account for their intracellular
growth [21]. Despite recent success there are still significant gaps
in the literature whether replication of M. avium is inhibited
directly by ERK1/2 or indirectly by inflammatory products of
ERK1/2 activation. For example, inhibitors of ERK1/2 such as
PD98059 inhibits p47 (phox) phosphorylation, an important
enzyme involved in the formation of reactive oxygen species
important for controlling bacterial replication [41]. Also PD98059
and U0126 lead to decreased secretion of cytokines such as TNF-a
thus further enhancing the growth of pathogenic mycobacteria in
human macrophages [21]. Considering our results showing that
ERK1/2 is highly active in M. avium-infected ECs compared to
infected-macrophages, one could speculate that a direct correla-
tion between high ERK1/2 activity and high levels of TNF-a
could exist, therefore placing TNF-a as a mediator of ERK1/2 in
the inhibition of M. avium growth in ECs. However, as previously
showed by our group the cytokine secretion profile in undifferen-
tiated macrophage and ECs revealed that IFN-c was almost
undetected in the supernatants of both cultures, irrespective if cells
were infected or not with M. avium [25]. Also, undifferentiated
macrophages and ECs similarly produced low TNF-a levels which
were increased in a time dependent manner in infected-
macrophages but not in infected-ECs [25]. Therefore, although
macrophages and ECs diverge in relation to TGF-b production,
IFN-c and TNF-a secretion levels were low in both cell types,
suggesting that endogenous TGF-b is not involved in the
regulation of these cytokines. Hence, the role of IFN-c and
TNF-a controlling bacilli replication may not be detrimental in our
cell system [25]. In this context, a recent report by Klug et al. [40]
has shown that replication of M. avium in macrophages is directly
influenced by ERK1/2 activity independently of TNF-a or IL-10,
two products of MAPK activation. In this study, the authors
showed that exogenous addition of TNF-a to TNF-a-deficient M.
avium-infected macrophages did not override the replication-
promoting effect of ERK1/2 inhibitor PD98059. Therefore, our
results showing that macrophages and ECs differ in the magnitude
and duration of ERK1/2 activity not only support an important
role for ERK1/2 in the control of M. avium replication, but also
add new insight about a growing concept that a qualitative and
quantitative ERK1/2 activity may generate variations in signaling
output that regulate cell fate decisions and therefore distinct
biological outcomes [42].
In addition to M. avium, the interaction of other granuloma-
inducing pathogens (P. brasiliensis and L. amazonensis) with ECs
showed that inhibition of intracellular parasites growth was
pathogen-dependent. Like M. avium, replication of P. brasiliensis
was counteracted in ECs, while L. amazonensis parasites underwent
replication above the rates seen in infected-macrophages. We
showed that TGF-b production by infected-ECs was similarly
high, irrespective of the nature of the infective pathogen,
suggesting that TGF-b-mediated activation of ERK1/2 might
exist in all infected-ECs. Therefore, it is possible that while high
levels of activated ERK1/2 contribute to the control of
intracellular replication of M. avium and P. brasiliensis, they may
not be sufficient to override L. amazonensis amastigotes growth.
However, replication of L. amazonensis amastigotes were enhanced
rather than inhibited in infected-ECs. We are currently investi-
gating the mechanism involved in this effect. We hypothesize that
an inhibitory effect induced by L. amazonensis itself in the control of
ERK1/2 activity may contribute to this effect. In line with this
argument, several studies have indicated that limited ERK
phosphorylation correlates with infection as both L. amazonensis
amastigotes and Leishmania donovani promastigotes have been
shown to prevent ERK1/2 activation while Leishmania mexicana
has been shown to promote ERK1/2 degradation [43,44,45].
A variety of clinical and experimental studies in many infectious
disease systems have demonstrated potent effects of TGF-b in the
regulation of microbial replication and host responses to
pathogens. In general, most pathogens that infect macrophages
including Toxoplasma gondii, Leishmania amazonensis, Trypanosoma cruzi
and the M. avium complex have evolved mechanisms to induce
TGF-b production, and TGF-b production in turn suppresses the
killing activity of macrophages, enhances intracellular proliferation
of the pathogen, and thus favors virulence [46,47,48]. Most of the
effects of TGF-b in promoting intracellular proliferation of
pathogens in infected-macrophages have been associated with its
indirect immunosuppressive properties [12,13,14]. Although our
results with infected-undifferentiated peritoneal macrophages
showed a tendency for diminution of TGF-b levels (Figures 2C,
3C and 6) and this was followed by increased M. avium replication,
it is important to consider that TGF-b production by infected-
macrophages may vary depending on the macrophages sources,
on distinct strains of M. avium as well as on the time course of
infection employed for detection of TGF-b production [49,50].
Moreover, some studies have demonstrated that TGF-b endoge-
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modulating anti-M. avium activity in infected-cells [51,52,53].
Therefore, our data showing that the magnitude and duration of
ERK1/2 activity are determinant to control intracellular M. avium
replication bring new perspectives to understand the influence of
TGF-b on host response depending on the context of ERK1/2
regulation. We showed that enhanced production of TGF-b by ECs
regulates high and sustained levels of ERK1/2 activity which favors
the inhibition of M. avium replication. We also propose that an
autocrinepositiveloop for TGF-b inthecontrolof ERK1/2 activity
might exist, since impairment of TGF-b signaling not only
downregulated TGF-b production but also ERK1/2 activity in
ECs (Fig. 7). Although the implication of this autocrine loop seems
to be of singular importance in the inhibition of M. avium growth in
ECs in vitro, further studies are required to evaluate its contribution
in granulomas in vivo. The granuloma structure is maintained and
stabilized by events mediated by both host and pathogen. It is
beneficial for the host as it helps to contain the infection to localized
regions. It is believed that bacteria can live for prolonged periods of
time within the environment of a granuloma [11], while at the same
time bacterial spreading to other areas of the organism is restricted
[54]. The mature granuloma is typically an area of localized
infection characterized by high levels of immunological activity
[55]. TGF-b has been found in epithelioid cells and in giant cells
during the morphogenesis of granulomas [56]. Therefore, an
appropriate TGF-b signaling may be one strategy to keep
intracellular pathogens replication under control and might also
contribute to maintain the infection in equilibrium during the
formation of granulomas harboring particular pathogens.
Materials and Methods
Animals
BALB/c pathogen free mice were obtained from the Center for
the Development of Experimental Models (CEDEME, UNIFESP,
Sa ˜o Paulo, SP, Brazil). All mouse procedures performed in this
study were reviewed and approved by the Institutional Ethics
Committee for Experimental Research of Federal University of
Sao Paulo (protocol # 01685/05).
Isolation and cultivation of resident peritoneal
macrophages and generation of ECs
Resident macrophages from 12-week-old BALB/c male mice
were obtained by rinsing the peritoneal cavity with 5 ml of cold
Hank’s Balanced Salt Solution ( HBSS) (Cultilab, Campinas, SP,
Brazil). Macrophages were stained with crystal violet and counted
in a Neubauer chamber. Cells were ressuspended in RPMI-1640
medium (Cultilab) and unless otherwise stated distributed on glass
coverslips placed into 24-well plates (5610
5 cells/well). For all
experiments, the suspension of peritoneal cells was left to adhere
for 30 min at 37uCi n5 %C O 2 atmosphere and then washed
thrice with PBS to remove nonadherent cells. The adhered cell
population was cultivated in complete RPMI medium buffered
with 10 mM HEPES plus 24 mM sodium bicarbonate, and
supplemented with 5% calf fetal serum (Cultilab), 40 mg l
21
gentamicin and in the presence or not of 50 ng ml
21 rIL-4 or
10 ng ml
21 rIL-13 (PeproTech Inc., Rocky Hill, NJ, USA) for 7
days, as described [24].
Mycobacterium avium culture
A virulent smooth transparent strain of M. avium, 62TL, was
grown in Middlebrook 7H9 liquid medium (Difco, Detroit, MI,
USA) supplemented with 10% OADC (oleic acid, albumin,
dextrose and catalase) (BD, Franklin Lakes, NJ, USA) for 15–20
days [57]. A standard curve relating the O.D.560 of the liquid
culture suspension and the number of corresponding colony
forming units (CFU) per ml, obtained through plating in 7H10
(Difco) solid medium (plus 10% OADC), was established to
estimate bacterial concentration. Aliquots of liquid medium log-
phase cultures were kept frozen without cryoprotector at 270uC
until use. The viability of the bacilli maintained as frozen stocks
was evaluated month by month during a year. For the
experiments, bacilli frozen up for two months, the most, were
employed. The frozen stocks were always thawed and immediately
ressupended in RPMI medium and the concentration of bacilli
was adjusted accordingly to a viability curve which was established
from frozen aliquots of M. avium thawed month by month. Cell
suspensions were serially diluted and plated on 7H10 solid
medium enriched with 10% OADC to count CFUs when colonies
were observed with naked eyes.
In vitro infection and analysis of mycobacterial growth
Seven days cultures of macrophages and ECs on glass coverslips
were washed three times with PBS to remove remaining culture
medium. A suspension of M. avium 62TL strain, in gentamicin/
FCS-free RPMI medium, was added at a ratio of 50 bacilli/cell to
the culture plates [58]. After 4 h of co-incubation, supernatants
were collected and non-internalized bacteria were eliminated by
washing three times with PBS. Cultures were replenished with
complete RPMI medium and followed for up to 96 h. Both,
supernatants and glass coverslips, were harvested at different
times. Supernatants were kept at 270uC until use and the cells
over glass slides were fixed with pure methanol and Ziehl Neelsen
stained. The number of bacteria inside both cell types and the
percentage of infected cells were calculated by observation under a
photomicroscope (Axiolab, Carl Zeiss, Germany).
Measurement of TGF-b
TGF-b levels present in the culture supernatants of macro-
phages and ECs were quantified by a sandwich ELISA kit (TGF-
Figure 7. Schematic model of TGF-b-mediated inhibition of M.
avium growth in infected-ECs. ECs produce high levels of TGF-b,
which in turn induce TGF-b receptor signaling leading to increased ERK
activity and also to auto-induction of TGF-b gene by an unknown
mechanism, resulting in an autocrine loop of activation. Increased and
sustained ERK1/2 activity impairs M. avium replication.
doi:10.1371/journal.pone.0021465.g007
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Systems, Minneapolis, MN, USA) and analysed at 492 nm (ELISA
reader; LabSystems Multiskan MS, Markham, Ontario, Canada).
TGF-b treatment of macrophages followed by M. avium
infection
Peritoneal macrophages were maintained for 7 days in culture
and then rTGF-b (PeproTech Inc.) was added or not to the
cultures, at a final concentration of 100 pg ml
21 4 h post-infection
with M. avium. Each 24 h post-infection cells were washed twice
with PBS and cultures were then replenished with complete RPMI
medium in the presence of 100 pg ml
21 rTGF-b during the
course of infection. Cells were always maintained at 37uC and 5%
CO2 atmosphere. Culture supernatants and glass coverslips were
harvested at each time point either for measurement of TGF-b
secretion or for mycobacterial growth, as described above.
Inhibition of TGF-b receptor kinase activity
Macrophages and ECs were serum starved overnight and then
pre-incubated or not with the TGF-b receptor kinase inhibitor,
SB431542 (Sigma, St. Louis, MO, USA), at a final concentration
of 10 mM, 1 h before M. avium infection. After that period cells
were washed twice with PBS and then submitted or not to
infection with M. avium in completed medium. Culture superna-
tants and glass coverslips were harvested at each time point during
the kinetics of infection either for measurement of TGF-b
secretion or for mycobacterial growth, as described above. For
detection of ERK1/2 phosphorylation in ECs treated with
SB431542, ECs were serum starved overnight and then pre-
treated or not with 10 mM SB431542 for 1 h. After that period
cells were washed twice with PBS and then submitted or not to
infection with M. avium in medium without serum. Four hours
post-infection cells were harvested and total cell extract were
produced for evaluation of ERK1/2 phosphorylation by immu-
noblot.
Immunoblot analysis of ERK K phosphorylation
For these assays 3610
7 cells were seeded in 100620 mm Petri
dishes. Total proteins from macrophages, infected or not with M.
avium (50:1) and treated or not with cytokines or pharmacological
inhibitors were extracted by addition of 100 ml lysis buffer (10%
NP-40, 150 mM NaCl, 50 mM Tris, 500 mM NaF) pH 7.4.
Protease inhibitors (1 mM PMSF, 10 mgm l
21 leupeptin and
10 mgm l
21 aprotinin) were always added to the lysis buffer
immediately before use. Protein extracts were obtained from cells
treated or not with rIL-4, or with the TGF-b receptor kinase
inhibitor SB431542. Samples were loaded under reducing
conditions on 10% SDS-polyacrylamide gels and then transferred
to PVDF membranes. After blockage with 5% defatted milk in
TRIS-buffered saline containing 0.1% Tween 20 (TTBS) (Sigma)
for 1 h, membranes were incubated with murine monoclonal
antibodies against phospho-ERK1/2 (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) or rabbit polyclonal antibodies against
ERK1/2 (Cell Signaling Technology, Danvers, MA, USA)
overnight at 4uC. Membranes were washed thrice with TTBS
and incubated for 1 h with the required horseradish peroxidase-
conjugated antibodies (Sigma). The activity of membrane-bound
peroxidase was detected by using enhanced chemiluminescent
method (Pierce Biotechnology, Rockford, IL, USA).
Inhibition of ERK1/2 phosphorylation with U0126
ECs were treated or not with 10 mM U0126 (Calbiochem, La Jolla,
CA, USA) for 24 h in medium without serum before M. avium
infection. After that period cells were washed twice with PBS and then
submitted or not to infection with M. avium in completed medium. At
each time point during a kinetic of 96 h of infection cells were
harvested and mycobacterial growth was evaluated as described above.
Infection of macrophages and ECs cultures with other
pathogens
Macrophages and ECs, cultivated on glass coverslips placed into
24-well plates, were incubated separately with a highly virulent
isolate of Paracoccidioides brasiliensis (Pb isolate 18), at a ratio of 5
fungi/cell [59] and Leishmania amazonensis, at a ratio of 2
amastigotes/cell [60]. The following steps were identical to those
mentioned above for M. avium. Material was fixed with methanol
for L. amazonensis infected cells and with 0,25% glutaraldehyde
(Sigma) for P. brasiliensis. Giemsa staining was employed for L.
amazonensis infected cells and none to analyse cells infection with P.
brasiliensis. The number of L. amazonensis inside infected cells was
counted in a Zeiss photomicroscope and P. brasiliensis in an
Olympus phase contrast microscope (CBA213 model).
Statistical analysis
The unpaired t-test was used to analyze data obtained from
experiments where two cell culture conditions were compared. For
all analysis, P,0.05 was considered statistically significant.
Supporting Information
Figure S1 M. avium 62TL strain growth curve in the
presence of different concentrations of rTGF-b. M. avium
were inoculated in 7H9-10% OADC medium in the presence or
absence of different concentrations of rTGF-b. Untreated (full
circle), 10 ng/ml rTGF-b (full square), 5 ng/ml rTGF-b (full
triangle), 2,5 ng/ml rTGF-b (open triangle). Optical density of
each culture was measured at 560 nm. Mean values are plotted
against time (in days).
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